Correlation Between Surrozen and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Surrozen and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Surrozen and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Monte Rosa.
Diversification Opportunities for Surrozen and Monte Rosa
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Surrozen and Monte is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Surrozen i.e., Surrozen and Monte Rosa go up and down completely randomly.
Pair Corralation between Surrozen and Monte Rosa
Given the investment horizon of 90 days Surrozen is expected to generate 1.23 times more return on investment than Monte Rosa. However, Surrozen is 1.23 times more volatile than Monte Rosa Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 1,346 in Surrozen on December 29, 2024 and sell it today you would lose (207.00) from holding Surrozen or give up 15.38% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Surrozen vs. Monte Rosa Therapeutics
Performance |
Timeline |
Surrozen |
Monte Rosa Therapeutics |
Surrozen and Monte Rosa Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Surrozen and Monte Rosa
The main advantage of trading using opposite Surrozen and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.Surrozen vs. Bolt Biotherapeutics | Surrozen vs. Larimar Therapeutics | Surrozen vs. Keros Therapeutics | Surrozen vs. Kezar Life Sciences |
Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |